![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 37636 |
FusionGeneSummary for TCTA_ARIH2 |
![]() |
Fusion gene information | Fusion gene name: TCTA_ARIH2 | Fusion gene ID: 37636 | Hgene | Tgene | Gene symbol | TCTA | ARIH2 | Gene ID | 6988 | 10425 |
Gene name | T cell leukemia translocation altered | ariadne RBR E3 ubiquitin protein ligase 2 | |
Synonyms | - | ARI2|TRIAD1 | |
Cytomap | 3p21.31 | 3p21.31 | |
Type of gene | protein-coding | protein-coding | |
Description | T-cell leukemia translocation-altered gene proteinT-cell leukemia translocation-associated gene protein | E3 ubiquitin-protein ligase ARIH2RING-type E3 ubiquitin transferase ARIH2all-trans retinoic acid inducible RING fingerariadne homolog 2protein ariadne-2 homolog | |
Modification date | 20180523 | 20180523 | |
UniProtAcc | P57738 | O95376 | |
Ensembl transtripts involved in fusion gene | ENST00000273590, ENST00000493381, | ENST00000356401, ENST00000449376, ENST00000490095, | |
Fusion gene scores | * DoF score | 3 X 4 X 3=36 | 9 X 10 X 4=360 |
# samples | 5 | 11 | |
** MAII score | log2(5/36*10)=0.473931188332412 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(11/360*10)=-1.71049338280502 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: TCTA [Title/Abstract] AND ARIH2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | TCTA | GO:0045671 | negative regulation of osteoclast differentiation | 19560569 |
Hgene | TCTA | GO:0072675 | osteoclast fusion | 19560569 |
Tgene | ARIH2 | GO:0000209 | protein polyubiquitination | 16118314|19340006 |
Tgene | ARIH2 | GO:0006511 | ubiquitin-dependent protein catabolic process | 16118314 |
Tgene | ARIH2 | GO:0016567 | protein ubiquitination | 24076655 |
Tgene | ARIH2 | GO:0048588 | developmental cell growth | 19340006 |
Tgene | ARIH2 | GO:0070534 | protein K63-linked ubiquitination | 19340006 |
Tgene | ARIH2 | GO:0070936 | protein K48-linked ubiquitination | 16118314|19340006 |
Tgene | ARIH2 | GO:0071425 | hematopoietic stem cell proliferation | 16118314|19340006 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | BRCA | TCGA-C8-A132-01A | TCTA | chr3 | 49450543 | + | ARIH2 | chr3 | 49019093 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000273590 | ENST00000356401 | TCTA | chr3 | 49450543 | + | ARIH2 | chr3 | 49019093 | + |
Frame-shift | ENST00000273590 | ENST00000449376 | TCTA | chr3 | 49450543 | + | ARIH2 | chr3 | 49019093 | + |
5CDS-intron | ENST00000273590 | ENST00000490095 | TCTA | chr3 | 49450543 | + | ARIH2 | chr3 | 49019093 | + |
3UTR-3CDS | ENST00000493381 | ENST00000356401 | TCTA | chr3 | 49450543 | + | ARIH2 | chr3 | 49019093 | + |
3UTR-3CDS | ENST00000493381 | ENST00000449376 | TCTA | chr3 | 49450543 | + | ARIH2 | chr3 | 49019093 | + |
3UTR-intron | ENST00000493381 | ENST00000490095 | TCTA | chr3 | 49450543 | + | ARIH2 | chr3 | 49019093 | + |
Top |
FusionProtFeatures for TCTA_ARIH2 |
![]() |
Hgene | Tgene |
TCTA | ARIH2 |
May be required for cellular fusion duringosteoclastogenesis. {ECO:0000269|PubMed:19560569}. | E3 ubiquitin-protein ligase, which catalyzesubiquitination of target proteins together with ubiquitin-conjugating enzyme E2 UBE2L3 (PubMed:16118314, PubMed:17646546,PubMed:19340006, PubMed:24076655). Acts as an atypical E3ubiquitin-protein ligase by working together with cullin-5-RINGubiquitin ligase complex (ECS complex, also named CRL5 complex)and initiating ubiquitination of ECS substrates: associates withECS complex and specifically mediates addition of the firstubiquitin on ECS targets (By similarity). The initial ubiquitin isthen elongated (By similarity). E3 ubiquitin-protein ligaseactivity is activated upon binding to neddylated form of the ECScomplex (PubMed:24076655). Mediates 'Lys-6', 'Lys-48'-and 'Lys-63'-linked polyubiquitination (PubMed:16118314, PubMed:17646546,PubMed:19340006). May play a role in myelopoiesis(PubMed:19340006). {ECO:0000250|UniProtKB:Q9Y4X5,ECO:0000269|PubMed:16118314, ECO:0000269|PubMed:17646546,ECO:0000269|PubMed:19340006, ECO:0000269|PubMed:24076655}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for TCTA_ARIH2 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for TCTA_ARIH2 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
TCTA | ATXN1, SMAD4 | ARIH2 | UGP2, BUB1, EML4, WDR91, KCNQ2, LOC147791, SGCE, CBR3, ENSA, IL4R, PPP2R1A, SLC1A6, ARAP1, DLST, KAT5, SCAMP2, UTP14A, KIAA1377, PTN, RPL8, TP53, EEF1A1, EEF1G, UBE2L3, GFI1, UBE2L6, UBE2E2, UBE2T, UBE2D1, UBE2D2, UBE2D3, UBE2D4, UBE2E1, UBE2E3, UBE2V1, UBE2R2, DISC1, PML, UBE2N, UBC, MDM2, NOTCH1, VCP, TRIM27, PHF7, RHEB, CUL5, NEDD8, ARIH2, APEX1, EHD1, PAPSS2, PARP6, PDLIM1, HK2, NUBP1, TWF2, PABPN1, REL, CCDC33, TCEB2, TCEB1, SOCS6, RAB40A, ASB9, ZFP41, NTRK1, BMX, TULP3, WSB2, PYCARD, NLRP3 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for TCTA_ARIH2 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for TCTA_ARIH2 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |